Holen Sie sich die Stockscreener-App
139.89
1.23%
1.70
Handel nachbörslich:
139.89
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$138.19
Offen:
$138.59
24-Stunden-Volumen:
794.93K
Relative Volume:
0.90
Marktkapitalisierung:
$10.56B
Einnahmen:
$12.82B
Nettoeinkommen (Verlust:
$936.34M
KGV:
13.03
EPS:
10.74
Netto-Cashflow:
$1.47B
1W Leistung:
-4.03%
1M Leistung:
+0.24%
6M Leistung:
-15.54%
1J Leistung:
+0.97%
1-Tages-Spanne:
$137.81
$140.42
1-Wochen-Bereich:
$136.50
$144.90
52-Wochen-Spanne:
$131.76
$179.60
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Vergleichen Sie DVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
139.89 | 10.96B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
378.81 | 93.08B | 71.59B | 5.78B | 4.95B | 22.49 |
|
THC
Tenet Healthcare Corp
|
165.10 | 15.54B | 20.52B | 1.46B | 1.41B | 15.12 |
|
EHC
Encompass Health Corp
|
121.01 | 12.21B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
192.42 | 12.68B | 16.08B | 1.20B | 1.06B | 17.82 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
DaVita: International Expansion And Buybacks Will Boost Returns (NYSE:DVA) - Seeking Alpha
DaVita Inc. (DVA) Stock Analysis: Evaluating a 17.96% Potential Upside in the Dialysis Market - DirectorsTalk Interviews
Ameriprise Financial Inc. Grows Stock Holdings in DaVita Inc. (NYSE:DVA) - Defense World
DaVita’s SWOT analysis: healthcare giant faces treatment growth hurdles - Investing.com Australia
DaVita Completes $1 Billion Senior Notes Offering - TipRanks
DaVita Inc. (DVA) Announces $750 Million Senior Notes Offering - GuruFocus
DaVita upsizes senior notes offering to $1 billion By Investing.com - Investing.com South Africa
DaVita launches $750 million senior notes offering By Investing.com - Investing.com South Africa
DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering - The Malaysian Reserve
DaVita (DVA) Announces Upsized $1 Billion Senior Notes Offering - GuruFocus
DaVita Upsizes Private Offering to $1 Billion - TipRanks
DaVita to offer $750M of senior notes in private offering - MSN
DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering | DVA Stock News - GuruFocus
DaVita upsizes senior notes offering to $1 billion - Investing.com
Davita Inc. Announces Upsize And Pricing Of $1 Billion Senior Notes Offering - marketscreener.com
DaVita Inc. Announces Offering of $750 Million Senior Notes - marketscreener.com
DaVita Begins Private Offering Of $750 Mln Of Senior Notes - Nasdaq
DaVita Announces $750M Senior Notes Offering - TipRanks
DaVita Launches $750 Million Senior Note Offering - marketscreener.com
DaVita launches $750 million senior notes offering - Investing.com Australia
DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship | DVA Stock News - GuruFocus
DaVita Inc. Announces Offering of $750 Million Senior Notes | DVA Stock News - GuruFocus
DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship - PR Newswire
DaVita (DVA) Stock Holds Steady as Truist Securities Lowers Pric - GuruFocus
Truist Adjusts DaVita (DVA) Price Target Downward | DVA Stock Ne - GuruFocus
Cowen cuts DaVita stock price target to $157 from $165 By Investing.com - Investing.com Nigeria
DaVita (DVA) Target Price Reduced by TD Cowen Analyst | DVA Stoc - GuruFocus
Cowen cuts DaVita stock price target to $157 from $165 - Investing.com
TD Cowen Adjusts Price Target on DaVita to $157 From $165, Maintains Hold Rating - marketscreener.com
Warren Buffett Sells $168M in DaVita Inc. (DVA) Shares - MSN
DaVita Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
DaVita’s Earnings Call: Balancing Achievements and Challenges - TipRanks
Here's Why DaVita HealthCare (DVA) is a Strong Growth Stock - Yahoo Finance
DaVita reiterates 2025 guidance amid cyber incident and expects phosphate binders to contribute at upper end of range - MSN
DaVita HealthCare (DVA) Q1 Earnings and Revenues Beat Estimates - MSN
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term - Yahoo Finance
DaVita Inc. (NYSE:DVA) Q1 2025 Earnings Call Transcript - Insider Monkey
DaVita Inc. (DVA): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying - Insider Monkey
DaVita accused of market collusion in class action lawsuit filed by food workers union - The Business Journals
DaVita Inc. to Participate in the Bank of America Securities 202 - GuruFocus
DaVita (DVA) Reports Strong Q1 Revenue | DVA Stock News - GuruFocus
DaVita Outshines Wall Street With First-Quarter Profit Beat - Finimize
DaVita Inc. 1st Quarter 2025 Results | DVA Stock News - GuruFocus
DaVita Stock Down Despite Q1 Earnings Beat, Margins Contract - TradingView
DaVita Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com
DaVita Inc (DVA) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Resilience - Yahoo Finance
DaVita Inc (DVA) Q1 2025 Earnings: EPS of $2.00 Beats Estimate, Revenue Reaches $3.224 Billion - GuruFocus
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):